Molecular Imaging Market Share, Growth by Top Company, Region, Review | FMI
Posted by ankush Nikam on January 27th, 2021
The global molecular imaging market is projected to register a CAGR of 7.5% in terms of value during the forecast period i.e. 2017–2027 and to be valued at US$ 6,445.8 Mn by 2027.
The report "Global Molecular Imaging Market, By Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), By Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others), By End User (Hospital, Diagnostic Imaging Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”
The prominent player operating in the global molecular imaging market includes Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.
Impact of Covid-19 pandemic on market
Due to the outbreak of Covid-19 pandemic globally, imaging modalities is widely preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging technologies involving nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. The increasing requirement for advanced imaging solutions is projected to drive the development studies globally. The report will account for Covid19 as a key market contributor.
Rising incidence of chronic disorders, improved digital platform penetration, and the increased use of molecular imaging in disciplines such as precision medicine the molecular imaging market is projected to register a steady growth. Additionally, the ongoing technological advancements have led to the identification of multimodality molecular imaging technology as an innovative approach for the anatomical as well as functional diagnosis. The use of multimodality imaging techniques including PET-CT, PET-MRI, and SPECT-CT is becoming gradually prevalent attributed to which the multimodality imaging technology is projected to lead the target market growth. Furthermore, with the advent of novel imaging agents counting the multimodality reporter genes is anticipated to rise the clinical application of techniques such as targeted molecular ultrasound and optical imaging because of which these segments are predicted to register an impressive CAGR in the coming years.
Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-724
Key Market Insights from the report:
Some Important Points Answered in this Market Report Are Given Below:
Like it? Share it!
About the Authorankush Nikam
Joined: December 21st, 2016
Articles Posted: 4,518
More by this author